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1. Introduction
Representatives of government health departments and patients’ organisations from all
European countries met with diabetes experts under the aegis of WHO Regional Offices for
Europe and the International Diabetes Federation (IDF), European region, in St Vincent, Italy
on 10–12 October 1989. Within this declaration of the five-year targets was to reduce by one
half the rates of limb amputations for diabetic gangrene.
There is an ongoing discussion whether this target could be achieved. In the recent years some
data were published presenting promising numbers of decreasing amputation rates.
2. United States
Rowe et al. analysed data from a Nationwide Inpatient Sample (NIS) from 1996-2005 in the
United States (Rowe et al. 2009). The NIS included 74 millions discharge records and was used
as source data regarding treatment patterns for patients with PAD. Since 1988, the NIS has
constructed a dataset comprising approximately 20% of the hospital discharges within the
United States. In order to develop a sample that most accurately represents the total universe
of domestic hospitalizations, hospitals are sampled according to specific characteristics
(strata), including geographic region, hospital ownership, urban/rural location, and teaching
status. Each discharge in the NIS dataset, therefore represents approximately five domestic
discharges. This 5:1 ratio is not constant across the NIS sample, however. Certain combinations
of strata may be under-sampled or over-sampled due to pragmatic considerations of sampling
design. When this occurs, the importance (weight) assigned to a specific hospitalization may
be greater or less than five. Unless specifically stated, all data and analyses in this study are
reported using the weighting scheme included with the NIS.
© 2013 Santosa and Kröger; licensee InTech. This is an open access article distributed under the terms of the
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Average annual admissions receiving major amputation in the years 1996 to 2005 were 41,275.
53.2% were females. Individuals undergoing major amputation were older (72.2 years) than
those that had open or endovascular procedures performed. The number of major amputations
fell significantly between 1996 and 2005, by an estimated 6.4% per year (P <0.05) (Fig 1). Rates
of decrease were more dramatic in the above 75 age group than in the younger age groups.
Figure 1. Rates of major amputation for peripheral arterial disease by age in the United States from 1996 to 2005.
Overall incidence rate reflects population-adjusted incidence rate among individuals aged 18years and older in the
United States (adjusted to 1996 population). (Rowe et al., 2009)
The authors also analyzed population-based rates of major amputation by diagnosis (PAD,
non-atheroslerotic PVD, infection, malignancy, trauma, and other/unspecified). The vast
majority of the reduction in population-based rates of major lower extremity amputations is
due to decreases in amputation rates for PAD (Fig. 2).
A more recent publication from Li et al. based on the same population analysed the period
from 1988 to 2008. The age-adjusted nontraumatic lower-extremity amputation per 1,000
persons among those diagnosed with diabetes and aged ≥40 years decreased from 11.2 in 1996
to 3.9 in 2008 (absolute percent -8.6%; P < 0.01), while rates among persons without diagnosed
diabetes changed little. (Li et al., 2012)
In 2009 Goodney et al. published data based on the Medicare population (Goodney et al.,
2009). The Medicare population included all people 65 years and older and regardless of age,
every citizen with a recognized disability and each citizen with acute renal failure, which
makes long-term dialysis or a kidney transplant needed. All Medicare claims from the Centers
for Medicare and Medicaid Services between 1996 and 2006, using the Medicare Physician/
Supplier Procedure Summary Master File were included. This is a 100% sample of all Part B
claims from all insurance carriers. Codes including a 250 modifier represented a procedure
done on both sides of the body; therefore, any code with this modifier was multiplied by two
in order to account for each limb. The absolute size of the Medicare population remained was
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rather stable over the study period, (31.7 million beneficiaries in 1996, 31.9 million beneficiaries
in 2006). Presented were only unadjusted data reported per 100,000 beneficiaries. Rates of
major amputations, defined as above-knee or below-knee amputation, coded according to
current procedural terminology were examined over the study period. Given that lesser
amputations at the metatarsal or single toe level are not generally considered failures of limb
salvage, amputations at lesser levels were not included in this analysis. To allow for compar‐
ison over time, annual rates were again normalized to reflect incidence rates per 100,000
Medicare beneficiaries, and RRs were calculated similarly as above. The author assumed that
the proportion of major lower extremity amputation due to peripheral vascular disease
remained constant over the study period, as prior analyses have demonstrated that fewer than
15% of major lower extremity amputations are traumatic in nature, and little change has
occurred in the incidence of traumatic amputation in recent years.
Figure 2. Rates of major amputation by indication in the United States from 1996 to 2005. Incidence rates are popula‐
tion-adjusted to 1996. (Rowe et al., 2009)
A distinct decline in the population based rates of major lower extremity amputation occurred
between 1996 and 2006 (Fig. 3)). Overall, the rate of below and above-knee amputation
decreased from 263 to 188 amputations per 100,000 Medicare beneficiaries, a 29% decline (RR
0.71, 95% CI 0.6-0.8). This decline began in 2000, and remains progressive throughout the next
6 years. Results were not different if above-knee amputations were studied distinctly from
below-knee amputations as both decreased in similar magnitude.
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Figure 3. Trends in endovascular interventions, major amputation, and lower extremity bypass surgery, 1996-2006.
RR,Risk ratio; CI, confidence interval. (Goodney et al., 2009)
3. Australia
In contrast to the data from the United States the number of diabetes-related hospitalisations
for major lower limb amputation did not show a significant trend in Far North Queensland,
Australia. (O’Rouke et al. 2012). There was a discrepancy of 6 (3.7%) in 161 cases over 10 years
from 1998-99 to 2007-08. The number of diabetes-related hospitalisations for major lower limb
amputation did not show a significant trend during this period, with an annual percentage
change of -0.32% (P=0.915). Thus, there was a modest reduction in the hospitalisation rate for
major lower limb amputation over the 10-year period only, demonstrating the need for
improvements in the organisation of care.
4. United Kingdom
Recent data from the United Kingdom are in line with the findings from Australia. Vamos et
al identified all patients aged >16 years who underwent any nontraumatic amputation in
England between 2004 and 2008 using national hospital activity data from all National Health
Service hospitals. During the study period the incidence of diabetes-related amputations
decreased by 9.1%, from 27.5 to 25.0 per 10,000 people with diabetes (p>0.2) (Fig. 4). The
incidence of minor and major amputations did not significantly change (15.7-14.9 and 11.8-10.2
per 10,000 people with diabetes; p=0.66 and p=0.29, respectively). Poisson regression analysis
showed no statistically significant change in diabetes-related amputation incidence over time
(0.98 decrease per year [95% CI 0.93-1.02]; p=0.12) (Vamos et a. 2010).
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Figure 4. Changes in minor and major amputation incidence rates in (A) individuals with diabetes expressed per
10,000 people with diabetes and (B) individuals without diabetes expressed per 100,000 people without diabetes.
(Vamos et al. 2010)
Incidence of lower extremity amputations was significantly higher among men than among
women with diabetes (P < 0.001). However, changes in overall lower extremity amputations
rates did not significantly differ between men and women (19.9 to 18.3 vs. 7.6 to 6.7 per 10,000
people with diabetes; P = 0.81). When stratified by age, the incidence was the highest among
individuals aged ≥65 years in both men and women. Poisson regression analysis showed no
significant decrease in incidence of amputations after adjustment for age, sex, year, and level
of amputation (0.98 decrease per year [95% CI 0.93–1.02]; P = 0.12).
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The number of people without diabetes who underwent a lower extremity amputations
decreased during the study period. Although the percentage of men undergoing minor
amputations increased significantly, male predominance was not evident among minor
amputees. Amputation incidence (minor and major combined) decreased from 13.6 per 100,000
people without diabetes in 2004 to 11.9 per 100,000 people without diabetes in 2008.
Incidence of minor lower extremity amputations decreased significantly from 5.9 to 5.0 per
100,000 people without diabetes (P < 0.01). There was a nonsignificant reduction in the
incidence of major lower extremity amputations among individuals without diabetes, from
7.7 to 6.9 per 100,000 people (P = 0.39) (Fig. 1).
The fall in lower extremity amputations rates was achieved between 2004 and 2006, and
incidence rates remained constant afterward for both minor and major procedures. Incidence
of lower extremity amputations declined among both men and women.
Poisson regression analysis showed that the decline in nondiabetes-related lower extremity
amputations was marginally significant after adjustment for age, sex, level of amputation, and
year (0.97 decrease by year [95% CI 0.93–1.00], P= 0.059).
5. Spain
A Spanish analysis did not report a decrease in the incidence of lower limb amputation in
Andalusia from 1998 to 2006 in the population with and without diabetes (Almaraz et al.,
2012). Andalusia, one of the 17th Spanish Autonomous Communities in Spain, had a total
population of 7,975,672 inhabitants in 2006. The Andalusian Health Service, guarantees health
care to almost 100% of the population (free, universal care). The information system is the same
for the whole of Andalusia and all main diagnosis from people admitted to hospital are
recorded in the CMBD (Conjunto Mı´nimo Ba´ sico de Datos, a basic set of data), at patient
discharge. This data collection (CMBD) is mandatory and this collection of data with a
standardized methodology was introduced in Spain in 1982. These data are registered in
accordance with the ICD-9-CM, and then send them to the Andalusian Health Service Central
Services.
During the study period 1998–2006 a total of 16,210 lower limb amputations were performed
in people aged ≥30 years old in Andalusia. Of these, 11,770 (72.6%) were in patients with
diabetes mellitus and 4440 (27.4%) in individuals without diabetes mellitus. The average age
of patients who underwent lower limb amputations was (mean ± SD): 70.6 ± 11.6 years; patients
with diabetes mellitus were aged 70.3 ± 10.7 years and patients without diabetes mellitus were
71.3 ± 13.7 years old ( p <0.05). In the population with diabetes the standardized incidence of
all lower limb amputation was found to be 34.0 per 10,000 (95% CI, 31.5-37.2) in 2004-2006.
There was an estimated incidence increase for all lower limb amputation by 14% and for minor
lower limb amputation by 13.6% in 2004-2006. In people with diabetes the RR increased by
31.6% as compared to the first period (Fig. 5).
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Figure 5. Changes in total, major and minor LLA incidence rates in patients with diabetes mellitus (A) and without
diabetes mellitus (B) expressed per 100,000 inhabitants. *p < 0.05 (Poisson regression analysis).(Almaraz et al. 2012)
6. Germany
In 2011 Moysidis et al published data from Germany based on the national statistics (DRG
statistics) provided from the Federal Statistical Office. The DRG-statistics include data from
all hospitals in Germany that use the DRG system, which are more than 99 %. These hospitals
are legally obliged to deliver extensive data on hospital treatment, including demographic
data, diagnoses, co-morbidities, complications, and procedures to the “Institute for the
Hospital Remuneration System” which uses the data for a yearly adaptation of the German
DRG system and transmits them to the Federal Statistical Office.
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Major amputation
total < 50 50-60 60-70 70-80 "/>80
all
2005 23.3 1 14 43 94 181
2006 22.6 1 14 41 87 173
2007 21.8 1 14 37 85 161
2008 21.0 1 13 36 79 153
Males
2005 27.0 1 22 67 135 216
2006 26.6 1 23 65 125 208
2007 25.6 2 22 59 124 180
2008 25.1 1 21 58 116 178
Females
2005 19.7 1 5 20 63 168
2006 18.7 1 6 18 57 158
2007 18.2 1 6 16 54 152
2008 17.1 1 5 16 49 142
Minor amputation
total < 50 50-60 60-70 70-80 "/>80
all
2005 35.0 3 31 79 144 183
2006 36.1 3 33 81 147 180
2007 36.6 3 33 78 148 180
2008 38.1 3 33 80 148 192
Males
2005 47.4 4 51 129 224 266
2006 49.5 4 54 133 230 259
2007 50.6 4 54 129 234 261
2008 53.7 4 55 134 240 285
Females
2005 23.1 2 12 31 83 150
2006 23.1 1 11 32 82 148
2007 23.1 2 12 29 80 146
2008 23.2 2 11 29 76 151
Table 1. Age-adjusted incidence of major (OPS 5 – 864) and minor (OPS 5 – 865) amputations per 100.000 inhabitants
in Germany from 2005 to 2008 excluding those patients amputated for injury and toxicity, musculoskeletal disorder,
diseases of skin and subcutaneous tissue and malignant neoplasm. (Moysidis et al. 2011)
The total number of patients hospitalised with the principal diagnosis peripheral arterial
disease and neurovascular disease increased from 163,520 in 2005 to 178,086 in 2008. Within
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the same time period the total number of major amputations decreased from 25,315 in 2005 to
23,009 in 2008 whilst the number of minor amputations increased form 37,690 in 2005 to 40,276
in 2008. After age adjustment major amputation rates still decreased for both genders (Tab.
1) Overall minor amputation rates do not show such a decrease but increased in males and
remained unchanged in females.
7. Discussion
All in all there is a great variation in the incidence of lower extremity amputations, even within
one country. In England the incidences of amputations in adults determined from hospital
episode statistics over 3 years to 31 March 2010 showed large variation between 151 Primary
Care Trusts. Incidence varied eightfold across Primary Care Trusts in people both with
diabetes (range 0.64-5.25 per 1,000 person-years) and without (0.03-0.24 per 1,000 person-
years). Amputations in people with diabetes varied tenfold-both major (range 0.22-2.20 per
1,000 person-years) and minor (range 0.30-3.25 per 1,000 person-years). (Holman et al. 2012).
Moxey et al. performed an electronic search using the EMBASE and MEDLINE databases from
1989 until 2010 for incidence of lower extremity amputation. There reviewed showed signifi‐
cant global variation exists in the incidence of lower extremity amputation. Incidence of all
forms of lower extremity amputation ranges from 46.1 to 9600 per 100.000 in the population
with diabetes compared with 5.8-31 per 100.000 in the total population. Major amputation
ranges from 5.6 to 600 per 100.000 in the population with diabetes and from 3.6 to 68.4 per
100.000 in the total population (Moxey et al., 2011). The authors mad the following conclusions:
• Significant reductions in incidence of lower extremity amputation have been shown in
specific at-risk populations after the introduction of specialist diabetic foot clinics.
• Ethnicity and social deprivation play a significant role but it is the role of diabetes and its
complications that is most profound.
• Lower extremity amputation reporting methods demonstrate significant variation with no
single standard upon which to benchmark care.
Thus, all data and the specific conclusion drawn from these data, respectively, have to be
handled with care as there are no lower extremity amputation reporting standards used that
would allow benchmark (Moxey et al., 2011). Especially data regarding minor amputation
rates can be assumed to underestimate the truth. An unknown but probably high number of
patients suffering from foot lesion is effectively treated in outdoor settings and do not appear
in the analysed data basis. In light of the rising prevalence of diabetes mellitus minor ampu‐
tations might mirror the burden of the problem more accurately, whereas major amputation
rates might give an insight in effectiveness of treatment strategies. Minor amputation rates
that do not decrease or even increase show that prevention of foot lesions is not effectively
achieved. Decreasing major amputations rates show, that if patients will get optimal treatment
this treatment is able to prevent deterioration of the lesion in some patients.
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